Cloning and Expression of CD19, a Human B-Cell Marker in NIH-3T3 Cell Line

BACKGROUND: CD19 is a pan B cell marker that is recognized as an attractive target for antibody-based therapy of B-cell disorders including autoimmune disease and hematological malignancies. The object of this study was to stably express the human CD19 antigen in the murine NIH-3T3 cell line aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbasi-Kenarsari, Hajar, Shafaghat, Farzaneh, Baradaran, Behzad, Movassaghpour, Ali Akbar, Shanehbandi, Dariush, Kazemi, Tohid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Research Institute 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388889/
https://www.ncbi.nlm.nih.gov/pubmed/25926951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388889/
https://www.ncbi.nlm.nih.gov/pubmed/25926951

Ejemplares similares